BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 34902118)

  • 1. Tools in Pharmacogenomics Biomarker Identification for Cancer Patients.
    Scionti F; Di Martino MT; Caracciolo D; Pensabene L; Tagliaferri P; Arbitrio M
    Methods Mol Biol; 2022; 2401():1-12. PubMed ID: 34902118
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacogenomics: Driving Personalized Medicine.
    Sadee W; Wang D; Hartmann K; Toland AE
    Pharmacol Rev; 2023 Jul; 75(4):789-814. PubMed ID: 36927888
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacogenomics Biomarker Discovery and Validation for Translation in Clinical Practice.
    Arbitrio M; Scionti F; Di Martino MT; Caracciolo D; Pensabene L; Tassone P; Tagliaferri P
    Clin Transl Sci; 2021 Jan; 14(1):113-119. PubMed ID: 33089968
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacogenomic Profiling of ADME Gene Variants: Current Challenges and Validation Perspectives.
    Arbitrio M; Di Martino MT; Scionti F; Barbieri V; Pensabene L; Tagliaferri P
    High Throughput; 2018 Dec; 7(4):. PubMed ID: 30567415
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacogenetics and pharmacogenomics as tools in cancer therapy.
    Rodríguez-Vicente AE; Lumbreras E; Hernández JM; Martín M; Calles A; Otín CL; Algarra SM; Páez D; Taron M
    Drug Metab Pers Ther; 2016 Mar; 31(1):25-34. PubMed ID: 26863347
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacogenomics and Personalized Medicine.
    Cecchin E; Stocco G
    Genes (Basel); 2020 Jun; 11(6):. PubMed ID: 32580376
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relevance of pharmacogenetics and pharmacogenomics in veterinary clinical practice: A review.
    Vaidhya A; Ghildiyal K; Rajawat D; Nayak SS; Parida S; Panigrahi M
    Anim Genet; 2024 Feb; 55(1):3-19. PubMed ID: 37990577
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacogenomics of soft tissue sarcomas: New horizons to understand efficacy and toxicity.
    Gambale E; Boddi A; Pasqui A; Campanacci DA; Scoccianti G; Palchetti I; Bernini A; Antonuzzo L; Pillozzi S
    Cancer Treat Res Commun; 2022; 31():100528. PubMed ID: 35123198
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DMET™ (Drug Metabolism Enzymes and Transporters): a pharmacogenomic platform for precision medicine.
    Arbitrio M; Di Martino MT; Scionti F; Agapito G; Guzzi PH; Cannataro M; Tassone P; Tagliaferri P
    Oncotarget; 2016 Aug; 7(33):54028-54050. PubMed ID: 27304055
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological Profile and Pharmacogenomics of Anti-Cancer Drugs Used for Targeted Therapy.
    Di Francia R; De Monaco A; Saggese M; Iaccarino G; Crisci S; Frigeri F; De Filippi R; Berretta M; Pinto A
    Curr Cancer Drug Targets; 2018; 18(5):499-511. PubMed ID: 28183252
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacogenomic biomarkers for personalized cancer treatment.
    Rodríguez-Antona C; Taron M
    J Intern Med; 2015 Feb; 277(2):201-217. PubMed ID: 25338550
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Personalized Medicine: Pharmacogenomics and Drug Development.
    Mirsadeghi S; Larijani B
    Acta Med Iran; 2017 Mar; 55(3):150-165. PubMed ID: 28282716
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacogenetics and pharmacogenomics in oncology therapeutic antibody development.
    Yan L; Beckman RA
    Biotechniques; 2005 Oct; 39(4):565-8. PubMed ID: 16235569
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacogenetics, pharmacogenomics, and individualized medicine.
    Ma Q; Lu AY
    Pharmacol Rev; 2011 Jun; 63(2):437-59. PubMed ID: 21436344
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role and impact of SNPs in pharmacogenomics and personalized medicine.
    Laing RE; Hess P; Shen Y; Wang J; Hu SX
    Curr Drug Metab; 2011 Jun; 12(5):460-86. PubMed ID: 21453271
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacogenomics in the age of personalized medicine.
    Dickmann LJ; Ware JA
    Drug Discov Today Technol; 2016; 21-22():11-16. PubMed ID: 27978982
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacogenomics and the future of toxicology testing.
    Agrawal YP; Rennert H
    Clin Lab Med; 2012 Sep; 32(3):509-23. PubMed ID: 22939305
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacogenomics, Pharmacokinetics, and Pharmacodynamics in the Era of Targeted Therapies.
    Calvo E; Walko C; Dees EC; Valenzuela B
    Am Soc Clin Oncol Educ Book; 2016; 35():e175-84. PubMed ID: 27249721
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug response in association with pharmacogenomics and pharmacomicrobiomics: towards a better personalized medicine.
    Hassan R; Allali I; Agamah FE; Elsheikh SSM; Thomford NE; Dandara C; Chimusa ER
    Brief Bioinform; 2021 Jul; 22(4):. PubMed ID: 33253350
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biomarkers: Delivering on the expectation of molecularly driven, quantitative health.
    Wilson JL; Altman RB
    Exp Biol Med (Maywood); 2018 Feb; 243(3):313-322. PubMed ID: 29199461
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.